Dose-dependent constipation with higher doses of quetiapine: a case series.

Standard

Dose-dependent constipation with higher doses of quetiapine: a case series. / Raedler, Thomas J; Reimer, Jens; Wiedemann, Klaus.

In: INT CLIN PSYCHOPHARM, Vol. 22, No. 4, 4, 2007, p. 244-246.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

APA

Vancouver

Bibtex

@article{56d2aa69e70644da8f82e78b7a794775,
title = "Dose-dependent constipation with higher doses of quetiapine: a case series.",
abstract = "Quetiapine is a dopamine D2 and serotonin 5-HT2 antagonist with antipsychotic and mood-stabilizing properties. Recent studies suggest that higher doses of quetiapine combine superior therapeutic efficacy with good tolerability. We present five patients, in whom treatment with higher doses of quetiapine was associated with constipation. Our observations raise the question of dose-dependent constipation under treatment with quetiapine.",
author = "Raedler, {Thomas J} and Jens Reimer and Klaus Wiedemann",
year = "2007",
language = "Deutsch",
volume = "22",
pages = "244--246",
journal = "INT CLIN PSYCHOPHARM",
issn = "0268-1315",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

RIS

TY - JOUR

T1 - Dose-dependent constipation with higher doses of quetiapine: a case series.

AU - Raedler, Thomas J

AU - Reimer, Jens

AU - Wiedemann, Klaus

PY - 2007

Y1 - 2007

N2 - Quetiapine is a dopamine D2 and serotonin 5-HT2 antagonist with antipsychotic and mood-stabilizing properties. Recent studies suggest that higher doses of quetiapine combine superior therapeutic efficacy with good tolerability. We present five patients, in whom treatment with higher doses of quetiapine was associated with constipation. Our observations raise the question of dose-dependent constipation under treatment with quetiapine.

AB - Quetiapine is a dopamine D2 and serotonin 5-HT2 antagonist with antipsychotic and mood-stabilizing properties. Recent studies suggest that higher doses of quetiapine combine superior therapeutic efficacy with good tolerability. We present five patients, in whom treatment with higher doses of quetiapine was associated with constipation. Our observations raise the question of dose-dependent constipation under treatment with quetiapine.

M3 - SCORING: Zeitschriftenaufsatz

VL - 22

SP - 244

EP - 246

JO - INT CLIN PSYCHOPHARM

JF - INT CLIN PSYCHOPHARM

SN - 0268-1315

IS - 4

M1 - 4

ER -